Abstract

Introduction: Tissue engineering is emerging as a therapeutic approach to overcome the limitations of cell therapy and mechanically support the ventricular wall. Tissue printing technology (TP) allows for the construction of a defined and organized tissue engineered construct. Hypothesis: The aim of our study was to evaluate the combination of TP and cardiac-derived cardiomyocyte progenitor cells (CMPCs) to build a cardiogenic construct. Methods: Sca-1 + CMPCs were printed in gelatin/hyaluronic acid matrix (30x10 6 cells/ ml) to form a biocomplex made of 6 perpendicularly printed layers with a surface of 2cm x 2cm and a structure 500 µm thick. After in vitro characterization, the printed biocomplex was transplanted in a mouse model of MI. Cardiac function was evaluated by MRI. Results: After printing, CMPCs retain cardiogenic gene expression for up to 4 weeks, as evaluated by PCR (n=4). Immunofluorescence analysis confirmed expression of Nkx2.5 and Ki67 with a slight decrease after 7 days in culture (77% vs 52% and 79% vs 64% respectively, n=5, p<0.05). After differentiation, hCMPCs increased MLC2a and TnI gene levels (n=4). In vivo engrafted hCMPCs expressed Nkx 2.5. TnI expression was also detected after 2 weeks (n=3) and 28 days (n=5). CD31 expression was detected in low number of transplanted hCMPCs. Endogenous CD45 expression was similar at 7 and 14 days, mainly localized at the border of the matrix (n=3). At 28 days, a reduction in EDV and ESV dilation was observed, as compared to control (EDV:107,87 ± 7,41 vs 136,6 ±9,6 and ESV:89 ± 6,6 vs 118 ±12, respectively, n=8 each group, p<0.05), although no significant differences could be observed with matrix only (EDV;107,87 ± 7,41 vs 120,8 ±9,5 and ESV;89 ± 6,6 vs 97 ±10, respectively, n=7). Infarct wall thinning was reduced in both groups compare to the control (457 ± 69,8 vs 357,8 ±18,6 and 201,1± 6,3 μ m, respectively; n=5 each group, p<0.05). Conclusion: Here, we showed that hCMPCs can be printed and cultured in Gel/ HA. Transplantation in a mouse model of MI contributed to an improvement in cardiac function and a better remodeling upon injury. Long-term follow up to address its effect on infarct size, cardiomyocytes survival and regeneration, revascularization, endogenous CPCs activation, and inflammation is ongoing.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.